Efficacy and safety of irinotecan-based therapy in elderly patients with advanced gastric cancer receiving third-line or later chemotherapy: post-hoc age-subgroup analysis of the rindberg trial

Ryohei Kawabata, Daisuke Sakai, Toshio Shimokawa, Rika Kizawa,Toru Ishiguro, Hiroki Yukami,Shogen Boku, Toshifumi Yamaguchi, Shunji Endo,Toshimasa Tsujinaka,Taroh Sato